Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
(June 9, 2007) The first documented lecture (by Shuji Ogino) that introduced “molecular pathologic epidemiology” at Harvard School of Public Health.
(June 3, 2011) First invited lecture on MPE (by Shuji Ogino) outside of the USA at International Symposium on Physiology and Diseases of the Digestive Tract, Orford, QC, Canada.
Expert Rev Mol Diagn 2012.
(February 6 or 7, 2014) The first documented lecture entitled “molecular pathological epidemiology” outside of the United StatesA. by an independent researcher (Rachel Hanisch) at IARC for the Early Career Scientists Association, in Lyon, France.
(May 12 and 13, 2016) The Third International Molecular Pathological Epidemiology (MPE) Meeting was held in Boston, MA, USA with approximately 150 attendees from 17 countries, and 400 accesses to livestreaming.
(December 6, 2017) The first comprehensive paper on the “pharmaco-MPE” paradigm (Ogino et al. npj Precis Oncol 2017) was published.
(May 17 to 18, 2018) ICMPE 2018: 20th International Conference on Molecular Pathological Epidemiology in Paris, France.
Rate how well Molecular epidemiology lives up to its initial vision.
Do you work at Molecular epidemiology?
Is Molecular epidemiology's vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| GENEWIZ | 1999 | $45.4M | 100 | - |
| Source Molecular | 2002 | $410,000 | 5 | - |
| 454 Life Sciences | 2005 | $19.4M | 100 | - |
| Institute for Systems Biology | 2000 | $37.5M | 230 | - |
| Admera Health | 2014 | $1.0M | 75 | - |
| Agdia | 1981 | $11.0M | 50 | - |
| Invisible Sentinel | 2006 | $9.0M | 39 | - |
| Genetics Institute | 1980 | $7.5M | 500 | - |
| Biocoat | 1991 | $10.9M | 20 | 16 |
| Lucigen | 1998 | $15.7M | 20 | - |
Zippia gives an in-depth look into the details of Molecular epidemiology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Molecular epidemiology. The employee data is based on information from people who have self-reported their past or current employments at Molecular epidemiology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Molecular epidemiology. The data presented on this page does not represent the view of Molecular epidemiology and its employees or that of Zippia.
Molecular epidemiology may also be known as or be related to Molecular Epidemiology Inc, Molecular Epidemiology Inc. and Molecular epidemiology.